Regular cannabis use does not appear to cause anemia in most people, and the largest population-level study on the topic actually found the opposite: current marijuana users had slightly higher hemoglobin levels than people who had never used it. But the full picture is more complicated than that reassuring headline. Specific situations, including pregnancy, synthetic cannabinoid use, and contaminated products, carry real hematological risks that blur the simple yes-or-no answer.
What the Largest Population Study Found
The most direct evidence comes from a study that analyzed data from roughly a decade of the National Health and Nutrition Examination Survey, a large ongoing U.S. government health survey. Researchers compared hemoglobin concentrations across people who had never used marijuana, former users, and current users. After adjusting for factors like age, sex, smoking status, and alcohol intake, current marijuana users had hemoglobin levels about 0.11 g/dL higher than never-users, and there was a clear dose-response trend: the more recent and frequent the use, the higher the hemoglobin.1Annals of the American Thoracic Society. Marijuana Use and Hemoglobin Concentrations in NHANES 2009–2018: Implications for Subclinical Hypoxemia That shift is small in absolute terms, but the direction matters: hemoglobin went up, not down. Anemia is defined by hemoglobin falling below a threshold, so this finding runs counter to the idea that cannabis causes it.
A separate study from Ghana looking at psychiatric hospital patients compared 92 non-users with 92 substance users broken into cannabis-only, alcohol-only, and dual-use groups. Hemoglobin was similar between non-users and cannabis-only users, reinforcing the NHANES picture. Dual users of cannabis and alcohol actually had significantly higher hemoglobin than non-users or alcohol-only users.2PubMed Central. Cannabis and Alcohol Use and Their Effects on Hematological and Biochemical Parameters: Evidence From the Accra Psychiatric Hospital, Ghana Neither of these studies points toward cannabis driving anemia in general adult users.
Why Hemoglobin Goes Up Instead of Down
The leading explanation for higher hemoglobin in cannabis smokers involves carbon monoxide. When marijuana is smoked, combustion produces carbon monoxide, which binds to hemoglobin in place of oxygen, forming carboxyhemoglobin. A classic comparison found that smoking marijuana produced nearly five times the rise in blood carboxyhemoglobin levels that smoking tobacco did, along with roughly three times more inhaled tar.3PubMed. Pulmonary hazards of smoking marijuana as compared with tobacco That extra carbon monoxide means less oxygen reaching your tissues. The body responds to this mild, chronic oxygen deficit the same way it responds to high altitude: it ramps up red blood cell production to compensate.
Researchers behind the NHANES analysis proposed this subclinical hypoxemia as the most likely mechanism. If the carbon monoxide from marijuana smoke quietly reduces oxygen delivery, the kidneys sense the shortfall and signal the bone marrow to make more red blood cells, which raises hemoglobin concentration over time.4Annals of the American Thoracic Society. Marijuana Use and Hemoglobin Concentrations in NHANES 2009–2018: Implications for Subclinical Hypoxemia – Section: Discussion They also acknowledged the possibility that cannabinoids could directly stimulate red blood cell production through pathways unrelated to oxygen sensing, though that remains speculative in humans.
This mechanism also explains why the effect is tied to smoking specifically. People who consume edibles or tinctures skip the combustion step entirely, so they would not experience the carbon monoxide exposure or the compensatory bump in hemoglobin. The study did not separate users by consumption method, so the hemoglobin rise likely reflects the dominance of smoking as the most common route.
Cannabinoid Receptors in Bone Marrow
Blood cells are manufactured in the bone marrow, and it turns out the bone marrow is wired into the body’s endocannabinoid system. Bone marrow stromal cells produce their own cannabinoid-like molecules, and the stem cells that give rise to blood cells carry cannabinoid receptors on their surfaces. When those receptors are activated by cannabinoid compounds, the stem cells show increased migration and colony formation, essentially becoming more active.5PubMed Central. Cannabinoid receptor 2 and its agonists mediate hematopoiesis and hematopoietic stem and progenitor cell mobilization Endocannabinoids like anandamide and 2-AG are secreted within the bone marrow’s stromal niche, suggesting this is part of the body’s normal blood-production machinery.6PubMed Central. Endocannabinoids are expressed in bone marrow stromal niches and play a role in interactions of hematopoietic stem and progenitor cells with the bone marrow microenvironment
What this means in practical terms is still unclear. Lab experiments showing that cannabinoid receptor activation can stimulate blood cell precursors do not automatically translate into what happens when a person smokes a joint. The doses, the timing, and the complex feedback loops that govern blood production in a living human body are all layers that lab models cannot replicate. But the finding does suggest that cannabinoids are not biologically inert when it comes to blood-cell production, and that the interaction is more likely to push cell activity up than to suppress it.
What Happens to Red Blood Cells in a Test Tube
When researchers expose red blood cells directly to THC or CBD in lab dishes, things look less benign. One study found that at concentrations of 50 nanograms per milliliter and above, both THC and CBD caused visible changes to red blood cell shape, including the formation of burr cells (spiky, distorted cells). At 100 nanograms per milliliter, fragmentation and degeneration became apparent. At a four-to-one ratio of THC to CBD, the damage was so severe that hardly any intact red blood cells remained.7PubMed Central. The in vitro effect of delta-9-tetrahydrocannabinol and cannabidiol on whole blood viscosity, elasticity and membrane integrity A separate experiment found that CBD triggered hemoglobin release from red blood cells and caused a transient burst of tiny membrane vesicles, suggesting the cell membranes were being disrupted.8Bentham Science Publishers. In vitro Effect of Cannabidiol on Red Blood Cells: Implication in Long-Lasting Pathology Treatment
These findings sound alarming, but they come with a major caveat: blood cells sitting in a dish are bathed in a constant concentration of cannabinoid with nowhere for it to go. In a living body, THC and CBD are rapidly distributed into fat tissue, metabolized by the liver, and present in the bloodstream only transiently and at much lower peak concentrations than the levels used in many lab experiments. The lowest concentrations tested (2.5 and 25 nanograms per milliliter) did not produce visible damage in the study. So the in vitro work tells us that cannabinoids can harm red blood cells under the right conditions, but it does not tell us those conditions are realistically achieved by smoking or eating cannabis.
Pregnancy Changes the Equation
One situation where the evidence does point toward a real anemia risk is pregnancy. A systematic review and meta-analysis pooling data from multiple studies found that women who used cannabis during pregnancy had about 36% higher odds of developing anemia compared with women who did not use cannabis.9PubMed Central. Prenatal exposure to cannabis and maternal and child health outcomes: a systematic review and meta-analysis The reasons are likely multifactorial. Pregnancy already stresses the body’s iron stores and blood volume. Cannabis use during pregnancy is also associated with other risk factors for anemia, including poorer nutrition and higher rates of tobacco co-use, making it hard to isolate cannabis as the sole cause. Still, the association held up in the pooled analysis and is worth knowing if you are pregnant or planning to become pregnant.
This is one of the few contexts where the data supports a direct link between cannabis and a higher risk of clinically meaningful anemia, rather than subclinical changes in lab values. Even if part of the effect is driven by confounding lifestyle factors, the combination of cannabis use with the already demanding hematological environment of pregnancy is concerning enough that most medical guidance recommends avoiding cannabis entirely during pregnancy.
Synthetic Cannabinoids Are a Different Animal
The question “can weed cause anemia” takes on a completely different character when the “weed” is not actually cannabis. Synthetic cannabinoids, sold under names like K2 or Spice, are chemically distinct from THC and carry risks that natural cannabis does not. A study of chronic synthetic cannabinoid users found hematological changes consistent with what the authors described as subclinical megaloblastic anemia with iron deficiency: blood iron-binding capacity was significantly elevated, and blood cell production appeared impaired.10PubMed Central. Alterations of the hematologic cells in synthetic cannabinoid users These users also had higher counts of inflammatory white blood cells, suggesting an ongoing inflammatory response that could further disrupt normal blood production.
The contamination risk makes things worse. In 2018, a wave of synthetic cannabinoid products in the United States turned out to be laced with brodifacoum, a potent rodenticide that works by blocking the blood’s clotting mechanism. People who used these products showed up in emergency rooms with bleeding that ranged from nosebleeds to life-threatening hemorrhage.11The Journal for Nurse Practitioners. Spontaneous Hemorrhage Associated With Synthetic Cannabinoid Use Severe, repeated bleeding from a contaminated product can obviously lead to anemia through sheer blood loss. Anyone buying unregulated cannabis products, especially anything sold as a synthetic, faces risks that go far beyond what THC itself does to the blood.
Heavy Metals in Cannabis Vapes
Contamination is not limited to synthetics. A scoping review of heavy metals in cannabis vaping devices found that structural elements of the cartridges and heating coils leach metals like nickel, chromium, lead, cobalt, cadmium, and copper into the aerosol that users inhale.12Hindawi / The Scientific World Journal. Heavy Metals in Cannabis Vapes and Their Health Implications-A Scoping Review None of the reviewed studies measured direct health outcomes, but several of these metals are well-established causes of anemia through other research. Lead, for instance, is one of the most thoroughly documented toxic causes of anemia: it interferes with the enzymes your body needs to make hemoglobin. Cadmium can damage the kidneys, which produce erythropoietin, the hormone that tells bone marrow to make red blood cells.
The practical takeaway is that the device and supply chain matter. A person using a regulated, lab-tested cannabis product through a clean delivery method faces a very different risk profile than someone hitting a cheap, unbranded vape cartridge. The anemia risk from cannabis vaping, to whatever extent it exists, is more about the hardware and the supply chain than about the cannabinoids themselves.
Long-Term Heavy Use and Hashish
One study from Morocco tracked blood parameters in young hashish smokers and found that with increasing duration and quantity of use, hemoglobin, red blood cell counts, and hematocrit all decreased.13AIMS Medical Science. The effects of smoking Haschich on blood parameters in young people from the Beni Mellal region Morocco This runs in the opposite direction from the NHANES data and deserves attention, but the study has limitations. It looked at a specific population of heavy hashish users in a single region, did not fully control for diet and overall health, and hashish products can vary enormously in composition and purity. Still, it raises the possibility that very heavy, long-term use patterns might shift the balance, especially if nutrition is poor or if the product contains adulterants.
The discrepancy between this finding and the NHANES results is not necessarily a contradiction. The NHANES sample captured the broad spectrum of American marijuana users, many of whom use casually or moderately. A cohort of dedicated, daily hashish smokers in Morocco represents the heavier end of the use spectrum. It is plausible that moderate cannabis smoking nudges hemoglobin up through the carbon monoxide mechanism, while very heavy or prolonged use eventually overwhelms that effect through nutritional depletion, chronic inflammation, or other pathways. The evidence is thin here, though, and no large controlled study has tracked heavy users over years specifically to watch for anemia.
Cannabis and Sickle Cell Disease
People with sickle cell disease already have a form of chronic anemia caused by abnormally shaped red blood cells. Cannabis use is common among sickle cell patients, primarily as a way to manage the severe pain crises the condition causes. Research into whether cannabinoids can help sickle cell pain has shown some promise in animal models, where cannabinoid receptor activation reduced mast cell activity and neurogenic inflammation, two key drivers of sickle cell pain.14PubMed Central. Cannabinoid receptor-specific mechanisms to alleviate pain in sickle cell anemia via inhibition of mast cell activation and neurogenic inflammation
But the relationship between cannabis and sickle cell disease is complicated by the same contamination risks that affect all cannabis users, amplified by the vulnerability of an already-compromised blood system. A review cautioned that unregulated cannabis products could contain adulterants that pose unique dangers to sickle cell patients, whose tolerance for additional hematological insults is narrow.15PubMed Central. Considerations for Cannabis Use to Treat Pain in Sickle Cell Disease For someone with sickle cell disease, the question is not really whether cannabis causes anemia (they already have it) but whether it worsens the underlying condition or interacts with their medications. The honest answer is that no one has studied this rigorously enough to say with confidence.
The Inflammation Angle
Chronic inflammation is one of the recognized pathways to anemia. When the body is dealing with persistent inflammation, it diverts iron away from red blood cell production as part of the immune response, leading to what is called anemia of chronic disease. This raises the question of whether cannabis’s effects on inflammation cut for or against anemia risk.
A systematic review of animal studies found that CBD, CBG, and CBD combined with THC consistently reduced levels of several key inflammatory molecules, including tumor necrosis factor alpha and interleukin-6. THC alone did not show the same anti-inflammatory effect on cytokine levels.16PubMed Central. The Effects of Cannabinoids on Pro- and Anti-Inflammatory Cytokines: A Systematic Review of In Vivo Studies If these anti-inflammatory effects translate to humans in a meaningful way, they could theoretically reduce the risk of inflammation-driven anemia rather than increase it. But the evidence base is almost entirely from animal models, and the doses and delivery methods used in those studies do not map neatly onto how people actually use cannabis. It is a suggestive signal, not a clinical recommendation.
Putting It Together for Everyday Users
For the average healthy adult using cannabis occasionally or moderately, the available evidence does not support a meaningful risk of anemia. The largest epidemiological data set shows hemoglobin going up, not down, and the biological mechanisms that would explain cannabis-induced anemia in healthy people remain theoretical or limited to test-tube conditions. Where the risk becomes real is in specific contexts: pregnancy, where anemia odds appear to rise; synthetic cannabinoid use, where both the drugs themselves and their common contaminants can damage blood production and cause bleeding; heavily contaminated products, where metals like lead can poison hemoglobin synthesis; and possibly very heavy, long-term use patterns, though the data here is sparse.
If you use cannabis and are worried about anemia, the most practical steps have nothing to do with quitting and everything to do with common sense. Eat enough iron-rich foods. If you vape, use tested products from licensed dispensaries rather than unbranded cartridges. Avoid synthetic cannabinoids entirely. And if you are pregnant or have a blood disorder like sickle cell disease, talk to your doctor before using any form of cannabis, because the risk calculus in those situations is genuinely different from what applies to the general population.